U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H17N5O7S
Molecular Weight 459.433
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Ervogastat metabolite M2

SMILES

OS(=O)(=O)OC1=CC=CN=C1OC2=CN=CC(=C2)C3=NC=C(C=N3)C(=O)N[C@H]4CCOC4

InChI

InChIKey=VIZUSIARYRKNAA-AWEZNQCLSA-N
InChI=1S/C19H17N5O7S/c25-18(24-14-3-5-29-11-14)13-8-22-17(23-9-13)12-6-15(10-20-7-12)30-19-16(2-1-4-21-19)31-32(26,27)28/h1-2,4,6-10,14H,3,5,11H2,(H,24,25)(H,26,27,28)/t14-/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H17N5O7S
Molecular Weight 459.433
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 19:27:35 UTC 2023
Edited
by admin
on Sat Dec 16 19:27:35 UTC 2023
Record UNII
QU9LFW2LKW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Ervogastat metabolite M2
Common Name English
(S)-2-((5-(5-((tetrahydrofuran-3-yl)carbamoyl)pyrimidin-2-yl)pyridin-3-yl)oxy)pyridin-3-yl hydrogen sulfate
Systematic Name English
Code System Code Type Description
PUBCHEM
166451428
Created by admin on Sat Dec 16 19:27:35 UTC 2023 , Edited by admin on Sat Dec 16 19:27:35 UTC 2023
PRIMARY
FDA UNII
QU9LFW2LKW
Created by admin on Sat Dec 16 19:27:35 UTC 2023 , Edited by admin on Sat Dec 16 19:27:35 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE